Finance

Lists
4DN:FRA
Denali Therapeutics Inc
€16.56
-1.95%
(-0.33) 1D
Oct 9, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 4DN...
Open
€16.56
High
€16.56
Low
€16.56
Mkt. cap
3.11B
Avg. vol.
43.00
Volume
0.00
52-wk high
€23.47
52-wk low
€12.32
No. of employees
507
Open
€16.56
High
€16.56
Low
€16.56
Mkt. cap
3.11B
Avg. vol.
43.00
Volume
0.00
52-wk high
€23.47
52-wk low
€12.32
No. of employees
507
News stories
From web sources and news partners
About Denali Therapeutics Inc
CEO-
Employees507
Founded2013
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitedenalitherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
3.60M
Cost of goods sold
101.95M
97.90M
103.85M
97.11M
Cost of revenue
101.95M
97.90M
103.85M
97.11M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
35.48M
39.46M
33.51M
36.28M
Operating expense
35.48M
39.46M
33.51M
36.28M
Total operating expenses
137.43M
137.36M
137.36M
133.40M
Operating income
-137.43M
-137.36M
-137.36M
-129.79M
Other non operating income
-
-
-
-
EBT including unusual items
-126.90M
-128.45M
-128.45M
-127.55M
EBT excluding unusual items
-126.90M
-130.09M
-129.71M
-126.80M
Income tax expense
-
102.00K
-
-
Effective tax rate
-
-0.08%
-
-
Other operating expenses
-
-
-
-
Net income
-126.90M
-128.55M
-128.45M
-127.55M
Net profit margin
-
-
-
-3,539.21%
Earnings per share
-0.74
-0.73
-0.69
-0.68
Interest and investment income
10.73M
7.28M
7.83M
3.17M
Interest expense
-200.00K
-
-179.00K
-178.00K
Net interest expenses
10.53M
7.28M
7.65M
2.99M
Depreciation and amortization charges
-
-
-
-
EBITDA
-133.57M
-133.58M
-133.60M
-125.31M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps